BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32029721)

  • 21. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
    Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
    Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression.
    Soliman ML; Rosenberger TA
    Mol Cell Biochem; 2011 Jun; 352(1-2):173-80. PubMed ID: 21359531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
    Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Analysis of Acetyl-CoA and Histone Modification via Mass Spectrometry to Investigate Metabolically Driven Acetylation.
    Sidoli S; Trefely S; Garcia BA; Carrer A
    Methods Mol Biol; 2019; 1928():125-147. PubMed ID: 30725455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
    Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
    Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Targeting of
    Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
    Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells.
    Poljaková J; Groh T; Gudino ZO; Hraběta J; Bořek-Dohalská L; Kizek R; Doktorová H; Eckschlager T; Stiborová M
    Oncol Rep; 2014 Apr; 31(4):1928-34. PubMed ID: 24481548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.
    Jiang D; Mo Q; Sun X; Wang X; Dong M; Zhang G; Chen F; Zhao Q
    Cancer Sci; 2021 Sep; 112(9):3585-3597. PubMed ID: 34252986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone hypoacetylation-activated genes are repressed by acetyl-CoA- and chromatin-mediated mechanism.
    Mehrotra S; Galdieri L; Zhang T; Zhang M; Pemberton LF; Vancura A
    Biochim Biophys Acta; 2014 Sep; 1839(9):751-63. PubMed ID: 24907648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of DHX33 in promoting Warburg effect via regulation of glycolytic genes.
    Peng C; Hou ST; Deng CX; Zhang Y
    J Cell Physiol; 2021 Feb; 236(2):981-996. PubMed ID: 32617965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation.
    Zhang M; Cong Q; Zhang XY; Zhang MX; Lu YY; Xu CJ
    J Cell Physiol; 2019 May; 234(5):6361-6370. PubMed ID: 30229902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma.
    Fang E; Wang J; Hong M; Zheng L; Tong Q
    Biochem Biophys Res Commun; 2019 Jan; 508(1):9-16. PubMed ID: 30466785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of pyruvate dehydrogenase by dichloroacetate has the potential to induce epigenetic remodeling in the heart.
    Matsuhashi T; Hishiki T; Zhou H; Ono T; Kaneda R; Iso T; Yamaguchi A; Endo J; Katsumata Y; Atsushi A; Yamamoto T; Shirakawa K; Yan X; Shinmura K; Suematsu M; Fukuda K; Sano M
    J Mol Cell Cardiol; 2015 May; 82():116-24. PubMed ID: 25744081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formaldehyde induces ferroptosis in hippocampal neuronal cells by upregulation of the Warburg effect.
    Li XN; Yang SQ; Li M; Li XS; Tian Q; Xiao F; Tang YY; Kang X; Wang CY; Zou W; Zhang P; Tang XQ
    Toxicology; 2021 Jan; 448():152650. PubMed ID: 33259821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
    Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
    PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetate reduces microglia inflammatory signaling in vitro.
    Soliman ML; Puig KL; Combs CK; Rosenberger TA
    J Neurochem; 2012 Nov; 123(4):555-67. PubMed ID: 22924711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAHA regulates histone acetylation, Butyrylation, and protein expression in neuroblastoma.
    Xu G; Wang J; Wu Z; Qian L; Dai L; Wan X; Tan M; Zhao Y; Wu Y
    J Proteome Res; 2014 Oct; 13(10):4211-9. PubMed ID: 25160476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.
    Wyce A; Ganji G; Smitheman KN; Chung CW; Korenchuk S; Bai Y; Barbash O; Le B; Craggs PD; McCabe MT; Kennedy-Wilson KM; Sanchez LV; Gosmini RL; Parr N; McHugh CF; Dhanak D; Prinjha RK; Auger KR; Tummino PJ
    PLoS One; 2013; 8(8):e72967. PubMed ID: 24009722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.